Effects of Methacrylic Acid on Physical/Mechanical Properties and Biocompatibility of Urethane-Based Denture Biomaterials


Candida-associated denture stomatitis (CADS) is a significant clinical concern. We have demonstrated that urethane-based denture biomaterials with 10% methacrylic acid (MAA) could bind and then slowly release antifungal drug for months. Drugs on the resins could be repeatedly quenched/recharged, and in subsequent recharging, they could be changed/switched to more potent/effective ones. However, the physical/mechanical properties and biocompatibility of the new MAA-based resins are currently unknown. The objective of the current study is to evaluate the effects of copolymerization with MAA on physical/mechanical properties and biocompatibility of urethane-based denture resin materials. MAA and diurethane dimethacrylate (UDMA) were copolymerized using initiator azobisisobutyronitrile (AIBN). Water sorption and solubility were assessed with the specifications of ISO (International Standards Organization) test method 1567, flexural strength and modulus were measured according to ASTM D-790, and biocompatibility was preliminarily evaluated in cytotoxicity assay using mouse 3T3 fibroblast cells with the trypan blue method. The results demonstrated that copolymerization of UDMA with up to 10% MAA did not negatively affect water sorption/solubility, flexural strength/modulus, and biocompatibility. With 20% MAA, however, the mechanical properties of the resulting resins were significantly decreased. To sum up, UDMA-MAA copolymers with up to 10% MAA had adequate physical/mechanical properties for denture materials with no side effects on cell viability. The UDMA-MAA denture biomaterials have a good potential to be used clinically for managing CADS and other related infectious conditions.

Share and Cite:

Cao, Z. , Sun, X. , Yeh, C. and Sun, Y. (2011) Effects of Methacrylic Acid on Physical/Mechanical Properties and Biocompatibility of Urethane-Based Denture Biomaterials. Materials Sciences and Applications, 2, 1070-1075. doi: 10.4236/msa.2011.28144.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] L. F. Perezous, C. M. Flaitz, M. E. Goldschmidt and R. L. Engelmeier, “Colonization of Candida Species in Denture Wearers with Emphasis on HIV Infection: A Literature Review,” Journal of Prosthetic Dentistry, Vol. 93, No. 3, 2005, pp. 288-293. doi:10.1016/j.prosdent.2004.11.015
[2] C. W. Douglass, A. Shih and L. Ostry, “Will There Be a Need for Complete Dentures in the United States in 2020?” Journal of Prosthetic Dentistry, Vol. 87, No. 1, 2002, pp. 5-8. doi:10.1067/mpr.2002.121203
[3] A. M. Iacopino and W. F. Wathen, “Oral Candidal Infection and Denture Stomatitis-a Comprehensive Review,” The Journal of the American Dental Association, Vol. 123, No. 1, 1992, pp. 46-51.
[4] T. M. Arendorf and D. M. Walker, “Denture Stomatitis: a Review,” Journal of Oral Rehabilitation, Vol. 14, No. 3, 1987, pp. 217-227. doi:10.1111/j.1365-2842.1987.tb00713.x
[5] E. Budtz-Jorgensen, “The Significance of Candida Albicans in Denture Stomatitis,” Scandinavian Journal of Dental Research, Vol. 82, No. 2, 1974, pp. 151-190.
[6] D. R. Radford, S. J. Challacombe and J. D. Walter, “Denture Plaque and Adherence of Candida Albicans to Denture-base Materials in Vivo and in Vitro,” Critical Reviews in Oral Biology & Medicine, Vol. 10, No. 1, 1999, pp. 99-116. doi:10.1177/10454411990100010501
[7] B. C. Webb, C. J. Thomas, M. D. Willcox, D. W. Harty and K. W. Knox, “Candida-associated Denture Stomatitis. Aetiology and Management: a Review. Part 1. Factors Influencing Distribution of Candida Species in the Oral Cavity,” Australian Dental Journal, Vol. 43, No. 1, 1998, pp. 45-50. doi:10.1111/j.1834-7819.1998.tb00152.x
[8] I. Olsen, “Denture stomatitis. Occurrence and distribution of fungi,” Acta Odontologica Scandinavica, Vol. 32, No. 5, 1974, pp. 329-333. doi:10.3109/00016357409002556
[9] G. Ramage, K. Tomsett, B. L. Wickes, J. L. Lopez-Ribot, and S. W. Redding, “Denture Stomatitis: a Role for Candida Biofilms,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics, Vol. 98, No. 1, 2004, pp. 53-59. doi:10.1016/j.tripleo.2003.04.002
[10] M. Golecka, U. Oldakowska-Jedynak, E. Mierzwinska- Nastalska and E. Adamczyk-Sosinska, “Candida-asoc- iated Denture Stomatitis in Patients after Immunosuppression Therapy,” Transplantation Proceedings, Vol. 38, No. 1, 2006, pp. 155-156. doi:10.1016/j.transproceed.2005.12.078
[11] C. A. Lefebvre, J. C. Wataha, R. M. Cibirka, G. S. Schuster and G. R. Parr, “Effects of Triclosan on the Cytotoxicity and Fungal Growth on a Soft Denture Liner,” Journal of Prosthetic Dentistry, Vol. 85, No. 4, 2001, pp. 352-356. doi:10.1067/mpr.2001.115249
[12] C. K. Chow, D. W. Matear and H. P. Lawrence, “Efficacy of Antifungal Agents in Tissue Conditioners in Treating Candidiasis,” Gerodontology, Vol. 16, No. 2, 1999, pp. 110-118. doi:10.1111/j.1741-2358.1999.00110.x
[13] Y. Abe, M. Ishii, M. Takeuchi, M. Ueshige, S. Tanaka and Y. Akagawa, “Effect of Saliva on an Antimicrobial Tissue Conditioner Containing Silver-zeolite,” Journal of Oral Rehabilitation, Vol. 31, No. 6, 2004, pp. 568-573. doi:10.1111/j.1365-2842.2004.01267.x
[14] C. Scully and G. McCarthy, “Management of Oral Health in Persons with HIV Infection,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, Vol. 73, No. 2, 1992, pp. 215-225.
[15] J. A. Phelan, B. R. Saltzman, G. H. Friedland and R. S. Klein, “Oral Findings in Patients with Acquired Immunodeficiency Syndrome,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, Vol. 64, No. 1, 1987, pp. 50-56.
[16] S. E. Park, R. Blissett, S. M. Susarla and H. P. Weber, “Candida Albicans Adherence to Surface-modified Denture Resin Surfaces,” Journal of Prosthodontics, Vol. 17, No. 5, 2008, pp. 365-369. doi:10.1111/j.1532-849X.2007.00292.xU
[17] D. M. Lin, S. Kalachandra, J. Valiyaparambil and S. Offenbacher, “A Polymeric Device for Delivery of Anti-microbial and Anti-fungal Drugs in the Oral Environment: Effect of Temperature and Medium on the Rate of Drug Release,” Dental Materials, Vol. 19, No. 7, 2003, pp. 589-596. doi:10.1016/S0109-5641(02)00109-4
[18] Z. Cao, X. Sun, C-K. Yeh andY. Sun, “Polyacrylic Acid Based Rechargeable Long-term Antifungal Denture Materials,” The 39th AADR Annual Meeting & Exhibition, Washington DC, 3-6 March, 2010.
[19] Z. Cao, X. Sun, C-K. Yeh and Y. Sun, “Rechargeable Infection-responsive Antifungal Denture Materials,” Journal of Dental Research, Vol. 89, No. 12, 2010, pp. 1517-1521. doi:10.1177/0022034510379604U
[20] S. H. Tuna, F. Keyf, H. O. Gumus and C. Uzun, “The Evaluation of Water Sorption/Solubility on Various Acry- lic Resins,” European Journal of Dentistry, Vol. 2, No. 3, 2008, pp. 191-197.
[21] U. Ortengren, H. Wellendorf, S. Karlsson and I. E. Ruyter, “Water Sorption and Solubility of Dental Composites and Identification of Monomers Released in an Aqueous Environment,” Journal of Oral Rehabilitation, Vol. 28, No. 12, 2001, pp. 1106-1115. doi:10.1046/j.1365-2842.2001.00802.x
[22] N. Beyth, I. Yudovin-Farber, R. Bahir, A. J. Domb and E. I. Weiss, “Antibacterial Activity of Dental Composites Containing Quaternary Ammonium Polyethylenimine Nanoparticles against Streptococcus Mutans,” Biomaterials, Vol. 27, No. 21, 2006, pp. 3995-4002. doi:10.1016/j.biomaterials.2006.03.003
[23] G. Dhir, D. W. Berzins, V. B. Dhuru, A. R. Periathamby and A. Dentino, “Physical Properties of Denture Base Resins Potentially Resistant to Candida Adhesion,” Journal of Prosthodontics, Vol. 16, No. 6, 2007, pp. 465-472. doi:10.1111/j.1532-849X.2007.00219.x
[24] P. Pfeiffer and E. U. Rosenbauer, “Residual Methyl Methacrylate Monomer, Water Sorption, and Water Solubility of Hypoallergenic Denture Base Materials,” Journal of Prosthetic Dentistry, Vol. 92, No. 1, 2004, pp. 72-78. doi:10.1016/j.prosdent.2004.04.003
[25] Y. S. Chang, C. L. Wu, S. H. Tseng, P. Y. Kuo and S. Y. Tseng, “Cytotoxicity of Triamcinolone Acetonide on Human Retinal Pigment Epithelial Cells,” Investigative Ophthalmology & Visual Science, Vol. 48, No. 6, 2007, pp. 2792-2798. doi:10.1167/iovs.06-1146
[26] T. J. Fruits, T. L. Coury, F. J. Miranda and M. G. Jr. Duncanson, “Uses and Properties of Current Glass Ionomer Cements: A Review,” General Dentistry, Vol. 44, No. 5, 1996, pp. 410-418.
[27] J. W. Nicholson, “Chemistry of Glass-ionomer Cements: A Review,” Biomaterials, Vol. 19, No. 6, 1998, pp. 485- 494. doi:10.1016/S0142-9612(97)00128-2
[28] G. J. Mount, “Glass Ionomers: A Review of their Current Status,” Operative Dentistry, Vol. 24, No. 2, 1999, pp. 115-124.
[29] M. A. A. De Bruyne and R. J. G. De Moor, “The Use of Glass Ionomer Cements in Both Conventional and Surgical Endodontics,” International Endodontic Journal, Vol. 37, No. 2, 2004, pp. 91-104. doi:10.1111/j.0143-2885.2004.00769.x
[30] R. Ghavamzadeh, V. Haddadi-Asl and H. Mirzadeh, “Bioadhesion and Biocompatibility Evaluations of Gelatin and Polyacrylic Acid as a Crosslinked Hydrogel in Vitro,” Journal of Biomaterials Science, Polymer Edition, Vol. 15, No. 8, 2004, pp. 1019-1031. doi:10.1163/1568562041526478
[31] X. Yan and R. A. Gemeinhart, “Cisplatin Delivery from Poly(Acrylic Acid-co-methyl Methacrylate) Microparticles,” Journal of Controlled Release, Vol. 106, No. 1-2, 2005, pp. 198-208. doi./10.1016/j.jconrel.2005.05.005
[32] M. Bohner, J. Lema?tre, H. P. Merkle and B. Gander, “Control of Gentamicin Release from a Calcium Phosphate Cement by Admixed Poly(Acrylic Acid),” Journal of Pharmaceutical Sciences, Vol. 89, No. 10, 2000, pp. 1262-1270. doi:10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.0.CO;2-7

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.